PolyPhotonix is a biophotonic research and development company that designs, develops and manufactures non-invasive photonic based medical devices. Established in 2009 in the North East of England, the company is focused on light therapy treatments for macular eye disease and has successfully brought its first medical device through clinical trials to market. The Noctura 400 Sleep Mask is a transformational treatment for Diabetic Retinopathy and Diabetic Macular Oedema, which are serious complications of diabetes and are the principal causes of blindness among people of working age in the UK. For more details visit our product website www.noctura.com. Contact us on: +44 (0) 1740 625 555 Email: enquiries@polyphotonix.com Website: www.polyphotonix.com
